Subscribe to our Newsletters !!

    ISO 13485

    Cipla Invests in iCaltech to Boost Respiratory Portfolio

    Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) announced today that it has signed definitive agreements for investment in Optionally Convertible Preference Shares of iCaltech Innovations Private Limited (hereafter referred to as “iCaltech”), subject to completion of certain conditions. Cipla Invests in iCaltech to Strengthen Respiratory Diagnostics Ecosystem in India

    How Single-Use Sterile Connectors Are Tested for Quality and Sterility

    Sterile-to-sterile (S2S) single-use connectors have become foundational technologies in modern biopharmaceutical manufacturing. As biologics, cell therapies, mRNA platforms, and highly potent drug products continue to drive flexible manufacturing strategies. The industry has increasingly shifted away from fixed stainless-steel transfer systems toward disposable closed fluid management technologies. In this transition, sterile connectors are no longer viewed